South Street Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $303K | Hold |
1,934
| – | – | 0.04% | 69 |
|
|
2026
Q1 | $295K | Hold |
1,934
| – | – | 0.04% | 69 |
|
|
2025
Q4 | $267K | Buy |
1,934
+34
| +2% | +$4.45K | 0.04% | 68 |
|
|
2025
Q3 | $244K | Buy |
+1,900
| New | +$232K | 0.03% | 76 |
|
|
2021
Q3 | – | Sell |
-2,600
| Closed | -$237K | – | 71 |
|
|
2021
Q2 | $237K | Hold |
2,600
| – | – | 0.04% | 63 |
|
|
2021
Q1 | $222K | Hold |
2,600
| – | – | 0.07% | 33 |
|
|
2020
Q4 | $246K | Hold |
2,600
| – | – | 0.05% | 57 |
|
|
2020
Q3 | $226K | Hold |
2,600
| – | – | 0.05% | 53 |
|
|
2020
Q2 | $227K | Hold |
2,600
| – | – | 0.06% | 56 |
|
|
2020
Q1 | $214K | Hold |
2,600
| – | – | 0.07% | 55 |
|
|
2019
Q4 | $246K | Hold |
2,600
| – | – | 0.06% | 58 |
|
|
2019
Q3 | $226K | Hold |
2,600
| – | – | 0.07% | 61 |
|
|
2019
Q2 | $237K | Sell |
2,600
-302
| -10% | -$25.6K | 0.07% | 63 |
|
|
2019
Q1 | $250K | Hold |
2,902
| – | – | 0.08% | 60 |
|
|
2018
Q4 | $223K | Hold |
2,902
| – | – | 0.08% | 56 |
|
|
2018
Q3 | $224K | Buy |
+2,902
| New | +$215K | 0.03% | 62 |
|
|
2018
Q2 | – | Sell |
-2,902
| Closed | -$210K | – | 65 |
|
|
2018
Q1 | $210K | Hold |
2,902
| – | – | 0.02% | 63 |
|
|
2017
Q4 | $218K | Hold |
2,902
| – | – | 0.07% | 59 |
|
|
2017
Q3 | $223K | Hold |
2,902
| – | – | 0.04% | 60 |
|
|
2017
Q2 | $217K | Buy |
+2,902
| New | +$206K | 0.07% | 60 |
|
|
2016
Q4 | – | Sell |
-2,902
| Closed | -$205K | – | 63 |
|
|
2016
Q3 | $205K | Sell |
2,902
-296
| -9% | -$21.6K | 0.06% | 60 |
|
|
2016
Q2 | $236K | Hold |
3,198
| – | – | 0.07% | 54 |
|
|
2016
Q1 | $207K | Buy |
3,198
+128
| +4% | +$8.71K | 0.07% | 55 |
|
|
2015
Q4 | $236K | Buy |
+3,070
| New | +$244K | 0.08% | 56 |
|
|
2015
Q2 | – | Sell |
-4,185
| Closed | -$347K | – | 59 |
|
|
2015
Q1 | $347K | Hold |
4,185
| – | – | 0.1% | 52 |
|
|
2014
Q4 | $347K | Sell |
4,185
-3,571
| -46% | -$296K | 0.11% | 48 |
|
|
2014
Q3 | $654K | Hold |
7,756
| – | – | 0.24% | 44 |
|
|
2014
Q2 | $629K | Hold |
7,756
| – | – | 0.18% | 42 |
|
|
2014
Q1 | $590K | Hold |
7,756
| – | – | 0.23% | 42 |
|
|
2013
Q4 | $558K | Hold |
7,756
| – | – | 0.23% | 42 |
|
|
2013
Q3 | $533K | Hold |
7,756
| – | – | 0.26% | 41 |
|
|
2013
Q2 | $491K | Buy |
+7,756
| New | +$505K | 0.26% | 39 |
|
Other funds holding NVS
South Street Advisors's NVS Position: Q2 2026 in Review
South Street Advisors held its Novartis (NVS) position steady in Q2 2026 at 1,934 shares worth $303K. The position accounts for 0.04% of the portfolio, ranked #69.
South Street Advisors first reported a position in NVS in Q2 2013 and has held it in 32 quarters since. The position peaked at $654K in Q3 2014. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- South Street Advisors held 1,934 shares of Novartis worth $303K as of Q2 2026.
- South Street Advisors left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.04% of South Street Advisors's portfolio in Q2 2026, its #69 holding.
- South Street Advisors first reported a position in Novartis in Q2 2013 and has held it in 32 quarters since.
- South Street Advisors's Novartis position peaked at $654K in Q3 2014.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on South Street Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.